Accretive Health (ACHI) Misses Q2 EPS by 29c

Accretive Health (: ACHI) reported Q2 EPS of ($0.27), $0.29 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $22.09 million versus the consensus estimate of $56.51 million.

For earnings history and earnings-related data on Accretive Health (ACHI) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Beike (BEKE) PT Raised to $23 at Morgan Stanley
• Is the global equity rally broadening? UBS weighs in